Abstract
Apolipoprotein B plays a central role in lipoprotein metabolism. Many studies have evaluated the association between Apolipoprotein B gene polymorphisms (XbaI, EcoRI, SpIns/Del, MspI) and the risk for coronary artery disease and myocardial infarction. However, the results remain inconsistent, particularly among different populations. To more precisely determine the association between Apolipoprotein B gene polymorphisms and coronary artery disease/myocardial infarction risk, we performed a meta-analysis via a comprehensive search of electronic databases (up to February 1st, 2015), odds ratios (OR) and 95 % confidence intervals were calculated using a fixed or random effect model. A total of 47 studies, with 9411 coronary artery disease/myocardial infarction cases and 9082 controls, were included in this meta-analysis. The combined results revealed significant associations between an increased risk of coronary artery disease/myocardial infarction and EcoRI (AA vs GG: OR 1.511, 95 % confidence interval (CI) 1.098, 2.078) and SpIns/Del (DD vs II: OR 1.331, 95 % CI 1.064, 1.665) alleles in the general population. In a subgroup analysis stratified by ethnicity, the T allele of the XbaI variant was associated with a decreased risk in Caucasians, whereas it was associated with an increased risk among the East Asian population. No significant correlation was detected between the A allele of the MspI variant and the coronary artery disease/myocardial infarction risk in either the general population or any ethnic subgroup. The results of our study suggest that Apolipoprotein B gene polymorphisms may affect the coronary artery disease/myocardial infarction susceptibility and these effects may display notable discrepancies among different populations.
Similar content being viewed by others
References
Aburatani H, Murase T, Takaku F (1987) Apolipoprotein B-gene polymorphism and myocardial infarction. N Engl J Med 317:52–53
Al-Bustan SA, Alkhalaf M, Al-Rashdan I, Al-Otaibi S, Al-Baker E, Balding D, Alnaqeeb MA (2009) Apolipoprotein E, CI and B gene polymorphisms in a sample of patients with coronary heart disease in the Kuwaiti population. Med Princ Pract 18:294–299
Anghebem-Oliveira MI, Picheth G, Prochaska CL, Scartezini M, Costantini CO, de Souza EM, Pedrosa FO (2009) Apolipoprotein B gene polymorphisms g.2488C>T and g.4154G>A are not associated with coronary artery disease in a Brazilian population. Clin Chim Acta 403:261
Benes P, Muzík J, Elbl L, Znojil V, Vácha J (2000) Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients. Atherosclerosis 152:257–258
Beneš P, Mužík J, Benedík J, Frélich M, Elbl L, Vašků A, Znojil V, Vácha J (2000) Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male caucasians. Mol Genet Metab 69:137–143
Benn M (2009) Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis 206:17–30
Benn M, Stene MC, Nordestgaard BG, Jensen GB, Steffensen R, Tybjaerg-Hansen A (2008) Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population. J Clin Endocrinol Metab 93:1038–1045
Berkinbayev S, Rysuly M, Mussayev A, Blum K, Baitasova N, Mussagaliyeva A, Dzhunusbekova G, Makhatov B, Mussayev A, Yeshmanova A et al (2014) Apolipoprotein gene polymorphisms (APOB, APOC111, APOE) in the development of coronary heart disease in ethnic groups of Kazakhstan. J Genet Syndr Gene Ther 5:216
Boekholdt SM, Peters RJ, Fountoulaki K, Kastelein JJ, Sijbrands EJ (2003) Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis. Hum Genet 113:417–425
Boerwinkle E, Chen SH, Visvikis S, Hanis CL, Siest G, Chan L (1991) Signal peptide-length variation in human apolipoprotein B gene. Molecular characteristics and association with plasma glucose levels. Diabetes 40:1539–1544
Bohn M, Bakken A, Erikssen J, Berg K (1993) XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI). Clin Genet 44:241–248
Bohn M, Bakken A, Erikssen J, Berg K (1994) The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clin Genet 45:255–259
Buraczynska M, Dzida G, Puzniak A, Sobstyl J, Hanzlik J (2000) Restriction fragment length polymorphisms in the apolipoprotein B gene in survivors of myocardial infarction. Med Sci Monit 6:882–886
Chiodini BD, Barlera S, Franzosi MG, Beceiro VL, Introna M, Tognoni G (2003) APO B gene polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis 167:355–366
Corbo RM, Vilardo T, Mantuano E, Ruggeri M, Gemma AT, Scacchi R (1997) Apolipoproteins B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet 52:77–82
de Almeida ER, Reiche EM, Kallaur AP, Flauzino T, Watanabe MA (2013) The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. BioMed Res Int 2013:1–15
De Lorenzo F, Rubba P, Monticelli A, Cocozza S (1993) Coronary heart disease, echo-Doppler evidence of peripheral arterial disease and polymorphism of apolipoprotein B gene and Apo AI/CIII cluster. Angiology 44:785–790
de Padua Mansur A, Annicchino-Bizzacchi J, Favarato D, Avakian SD, Machado Cesar LA, Franchini Ramires JA (2000) Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease. Am J Cardiol 85:1089–1093
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Ding K, Kullo IJ (2011) Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease. BMC Med Genet 12:55
Duman BS, Türkoğlu C, Akpinar B, Güden M, Vertii A, Cağatay P, Günay D, Sevim Büyükdevrim A (2005) Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease. Ann Hum Biol 32:620–629
Dunning AM, Renges HH, Hamsten A, Talmud P, Humphries S (1993) A postulated phylogenetic tree for the human apolipoprotein B gene: unpredicted haplotypes are associated with elevated apo B levels. Biochim Biophys Acta 1165:271–278
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Ferns GA, Galton DJ (1986) Frequency of XbaI polymorphism in myocardial infarct survivors. Lancet 2:572
Gallegos-Arreola MP, Valdez Y, Zúñiga-Corona M, Figuera LE, Arnaud-López L, Robles-Cervantes JA, González-Ortiz M, Martínez-Abundis E, Puebla-Pérez AM, Zúñiga-González GM (2012) Association between the Xba I polymorphism of APOB gene and plasma lipid level in Mexican patients with coronary artery disease. Asia Pac J Clin Nutr 21:312–318
Gardemann A, Ohly D, Fink M, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W (1998) Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction. Atherosclerosis 141:167–175
Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem DN, Wilson PW, Masharani U, Frossard PM (1990) DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82:7–17
Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL (1986) Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 315:1509–1515
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Hong SH, Song J, Kim JQ (2001) The haplotype analyses using multiple markers of the apolipoprotein B gene in patients with coronary artery disease. J Korean Med Sci 16:719–724
Hosking JL, Bais R, Sobecki SK, Tallis GA, Bradley J, Thomas DW (1992) Lipid parameters and apolipoprotein B RFLP studies: comparison of normal and coronary heart disease groups as defined by angiography. Clin Biochem 25:303–308
Huang LS, de Graaf J, Breslow JL (1988) ApoB gene MspI RFLP in exon 26 changes amino acid 3611 from Arg to Gln. J Lipid Res 29:63–67
Huang G, Zhong H, Re HM, Mao HW, Niu Q, Chi YH (2012) Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks. J Geriatr Cardiol 9:33–37
Huijgen R, Sjouke B, Vis K, de Randamie JS, Defesche JC, Kastelein JJ, Hovingh GK, Fouchier SW (2012) Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels. Hum Mutat 33:448–455
Kallel A, Ben Ali S, Sediri Y, Chabrak S, Elasmi M, Sanhaji H, Souheil O, Haj-Taieb S, Feki M, Mechmeche R et al (2008) Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction in Tunisian patients. Clin Chem Lab Med 46:1097–1101
Lamon-Fava S, Jimenez D, Christian JC, Fabsitz RR, Reed T, Carmelli D, Castelli WP, Ordovas JM, Wilson PW, Schaefer EJ (1991) The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 91:97–106
Li YY (2014) ApoB gene SpIns/Del, XbaI polymorphisms and myocardial infarction: a meta-analysis of 7169 participants. J Cardiovasc Med 15:717–726
Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O’Brien TR et al (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156:300–310
Ludwig EH, Blackhart BD, Pierotti VR, Caiati L, Fortier C, Knott T, Scott J, Mahley RW, Levy-Wilson B, McCarthy BJ (1987) DNA sequence of the human apolipoprotein B gene. DNA 6:363–372
Machado MO, Hirata MH, Bertolami MC, Hirata RD (2001) Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal 15:19–24
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, Allen A, Karagounis LA, Ward RH (1994) Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation 89:567–577
Mendis S, Shepherd J, Packard CJ, Gaffney D (1991) Restriction fragment length polymorphisms in the Apo B gene in relation to coronary heart disease in a southern Asian population. Clin Chim Acta 196:107–117
Miettinen HE, Korpela K, Hämäläinen L, Kontula K (1994) Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 94:189–192
Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D, Humphries SE (1989) Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease. Atherosclerosis 77:193–201
Nieminen MS, Mattila KJ, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen MR (1992) Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb Vasc 12:58–69
Pan JP, Chiang AN, Tai JJ, Wang SP, Chang MS (1995) Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clin Chem 41:424–429
Paulweber B, Friedl W, Krempler F, Humphries SE, Sandhofer F (1990) Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis 10:17–24
Rantala M, Rantala TT, Savolainen MJ, Friedlander Y, Kesäniemi YA (2000) Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am J Clin Nutr 71:713–724
Rebhi L, Omezzine A, Kchok K, Belkahla R, Ben Hadjmbarek I, Rejeb J, Ben Rejeb N, Nabli N, Bibi A, Massoud T et al (2008) 5′ ins/del and 3′ VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease. Clin Chem Lab Med 46:329–334
Ryckman K, Williams SM (2008) Calculation and use of the Hardy–Weinberg model in association studies. Curr Protoc Hum Genet 57:1.18.1–1.18.11
Saha N, Tong MC, Tay JS, Jeyaseelan K, Humphries SE (1992) DNA polymorphisms of the apolipoprotein B gene in Chinese coronary artery disease patients. Clin Genet 42:164–170
Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, Hirata RD (2000) Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta 300:139–149
Scartezini M, Zago MA, Chautard-Freire-Maia EA, Pazin-Filho A, Marin-Neto JA, Hotta JK, Nascimento AJ, Dos-Santos JE (2003) The X-X-/E+E+genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample. Braz J Med Biol Res 36:369–375
Soria LF, Ludwig EH, Clarke HR, Vega GL, Grundy SM, McCarthy BJ (1989) Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A 86:587–591
Stepanov VA, Puzyrev VP, Karpov RS, Kutmin AI (1998) Genetic markers in coronary artery disease in a Russian population. Hum Biol 70:47–57
Takeuchi F, Isono M, Katsuya T, Yokota M, Yamamoto K, Nabika T, Shimokawa K, Nakashima E, Sugiyama T, Rakugi H (2012) Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals. PLoS One 7:e46385
Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE (1991) Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 89:69–81
Tyroler HA (1987) Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation 76:515–522
Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest G, Cambien F (1993) Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. “The ECTIM study”. Hum Genet 90:561–565
Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033
Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17:1410–1422
Wiklund O, Darnfors C, Bjursell G, Nilsson J, Linde’n T, Olofsson SO, Wilhelmsen L, Bondjers G (1989) XbaI restriction fragment length polymorphism of apolipoprotein B in Swedish myocardial infarction patients. Eur J Clin Invest 19:255–258
Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM et al (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161–169
Wu JH, Wen MS, Lo SK, Chern MS (1994) Increased frequency of apolipoprotein B signal peptide sp24/24 in patients with coronary artery disease. General allele survey in the population of Taiwan and comparison with Caucasians. Clin Genet 45:250–254
Xu Q, Zhou X (1998) Analysis of apolipoprotein B gene MspI, polymorphism and its clinical application. J Clin Lab (Chinese) 16:199–202
Yan SK, Li LX, Song YH (2003) Relationship between coronary heart disease and EcoRI & MspI polymorphisms of apolipoprotein B gene in Han nationality. Chin J Lab Med (Chinese) 26:5
Ye P, Chen BS, Wang SW (1994) Polymorphisms of apolipoprotein B gene in relation to coronary heart disease in Chinese Han nationality. Chin Med J 107:30–35
Ye P, Chen B, Wang S (1995) Association of polymorphisms of the apolipoprotein B gene with coronary heart disease in Han Chinese. Atherosclerosis 117:43–50
Zang B, Li HN, Guo JJ, Wu KG (2001) The relation between polymorphisms of apliporprotein B gene and myocardial infarction. Chin J Pract Intern Med 21:2
Zhang HQ, Yu K, Huang WJ, Lin J, Shi CG (2002) To explore the relativity of apolipoprotein B and E gene polymorphism with coronary heart disease and hypertension. Prev Treat Cardio-Cerebral-Vasc Dis (Chinese) 2:20–22
Zhang CJ, Mao Y, He CX (2010) Relationship Between Coronary Heart Disease with Diabetes and EcoRI Polymorphism ofApolipoprotein B Gene in Uygur and Han Nationality. Chin J Arteriosclerosis 18:5
Acknowledgments
We gratefully acknowledge Naping Tang for his assistance in proof-reading in this manuscript. This work is supported by grants from the National High-tech Research and Development Program of China (2012AA02A510, Beijing, China) and the Chinese National Nature Science Foundation (Grant No. 81370219, Beijing, China).
Conflict of interest
The authors declare that they have no conflict interests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Fig. S1
Flow diagram of the study selection process. Supplementary material 2 (TIFF 317 kb)
Rights and permissions
About this article
Cite this article
Xiao, D., Huang, K., Chen, Q. et al. Four Apolipoprotein B gene polymorphisms and the risk for coronary artery disease: a meta-analysis of 47 studies. Genes Genom 37, 621–632 (2015). https://doi.org/10.1007/s13258-015-0292-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-015-0292-3